Clinical Trial Update: Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) [NA]

View source ↗

Summary

A clinical trial update focusing on characterizing and managing metabolic dysfunction-associated fatty liver disease (MAFLD) and its associated steatohepatitis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatohepatitis
• Metabolic-associated Fatty Liver Disease
• Obesity

Snippet

Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval | Conditions: Metabolic Associated Fatty Liver Disease, Metabolic Associated-dysfunction Steatohepatitis (MASH) | NA | Status: NOT_YET_RECRUITING